ProQR Therapeutics (PRQR) Net Income (QoQ) (2013 - 2026)
ProQR Therapeutics (PRQR) Net Income (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,930.48 Bn | 1,930.42 Bn | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - |
| 4 | BeOne Medicines | 468.55 Bn | 463.76 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.04 Bn | 115.79 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.31 Bn | 61.56 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.40 Bn | 63.40 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 183.86 Mn | 91.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.03% |
| Dec 31, 2025 | 8.60% |
| Sep 30, 2025 | 9.36% |
| Jun 30, 2025 | -16.20% |
| Mar 31, 2025 | -17.27% |
| Dec 31, 2024 | -9.90% |
| Sep 30, 2024 | -162.23% |
| Jun 30, 2024 | 59.59% |
| Mar 31, 2024 | -12.45% |
| Dec 31, 2023 | -25.55% |
| Sep 30, 2023 | 32.76% |
| Jun 30, 2023 | 8.97% |
| Mar 31, 2023 | 34.37% |
| Dec 31, 2022 | 41.76% |
| Sep 30, 2022 | -72.33% |
| Jun 30, 2022 | 4.68% |
| Mar 31, 2022 | 22.49% |
| Dec 31, 2021 | -21.31% |
| Sep 30, 2021 | 4.14% |
| Jun 30, 2021 | -24.14% |